P T Lois Edelstein

Learn More
Conflicting reports concerning cholinomimetic-induced reduction of schizophrenic symptoms prompted the authors to study such changes in schizophrenic symptoms following physostigmine infusions in subgroups of patients with schizophrenic-like illness. These subgroups were defined by the presence or absence of antipsychotic response during a 2-week trial of(More)
Background. While recent studies have identified the existence of neighborhood-level factors that influence the carriage of S. pneumoniae, no studies have extended this observation to determine whether substantial small area variation exists in the risk of pneumococcal disease. Methods. Data from population based surveillance for bacteremic pneumococcal(More)
  • 1